ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

REVB Revelation Biosciences Inc

2.35
0.00 (0.00%)
Pre Mercado
Última actualización: 07:58:29
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Revelation Biosciences Inc REVB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 2.35 07:58:29
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.35
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/3/202415:15BWRevelation Biosciences, Inc. Announces Financial Results for..
13/3/202408:00BWRevelation Biosciences Inc. Gives Oral Presentation at..
12/3/202408:00BWRevelation Biosciences Inc. to Participate in a Virtual..
04/3/202408:00BWRevelation Biosciences Inc. Announces Commencement of First..
13/2/202419:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202408:00BWRevelation Biosciences Inc. Receives Invitation to Give an..
12/2/202409:19EDGAR2Form SCHEDULE 13G/A - Statement of acquisition of beneficial..
08/2/202415:01EDGAR2Form 8-K - Current report
05/2/202415:41BWRevelation Biosciences Inc. Announces Closing of $6.2..
02/2/202415:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/2/202405:00BWRevelation Biosciences Inc. Announces Pricing of $6.2..
30/1/202416:21EDGAR2Form 8-K - Current report
30/1/202414:32EDGAR2Form S-1/A - General form for registration of securities..
30/1/202408:00BWRevelation Biosciences Inc. to Present at The International..
29/1/202416:32EDGAR2Form S-1/A - General form for registration of securities..
23/1/202415:18EDGAR2Form 8-K - Current report
23/1/202408:00BWRevelation Biosciences Inc. Announces 1-for-30 Reverse Stock..
22/1/202415:01EDGAR2Form 8-K - Current report
22/12/202316:06EDGAR2Form DEF 14A - Other definitive proxy statements
22/12/202312:23EDGAR2Form S-1 - General form for registration of securities under..
12/12/202315:59EDGAR2Form PRE 14A - Other preliminary proxy statements
13/11/202315:30EDGAR2Form 8-K - Current report
13/11/202315:05BWRevelation Biosciences, Inc. Announces Financial Results for..
09/11/202315:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/10/202315:26EDGAR2Form 8-K - Current report
12/10/202308:00BWGemini Induces Pharmacologic Activity and Related..
04/10/202308:00BWRevelation Biosciences, Inc. to Present at the 2023 ROTH..
02/10/202315:24EDGAR2Form 8-K - Current report
02/10/202308:00BWRevelation Biosciences Inc. Announces Appointment of Lakhmir..
11/8/202315:30EDGAR2Form 8-K - Current report
11/8/202315:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/8/202315:10BWRevelation Biosciences Inc. Announces Financial Results for..
11/8/202315:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202315:05EDGAR2Form 8-K - Current report
14/7/202315:51EDGAR2Form 8-K - Current report
07/7/202315:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/7/202315:07EDGAR2Form 8-K - Current report
29/6/202315:23EDGAR2Form 8-K - Current report
29/6/202308:00BWREMINDER: Revelation Biosciences, Inc. Urges All..
12/6/202315:15BWRevelation Biosciences Inc. Announces Adjournment of 2023..
22/5/202308:00BWRevelation Biosciences Inc. Announces Financial Results for..

Su Consulta Reciente

Delayed Upgrade Clock